Cytokines and alcoholic liver disease

Alcohol Research and Health

Volumn 21, Issue 4, 1997, Pages 317-320

  McClain, Craig J ^a   Shedlofsky, Steven ^b   Barve, Shirish ^a   Hill, Daniell B ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver disorder; AODE (alcohol and other drug effects); Blood proteins; Cytokines; Drug theapy; Endotoxins; Immune response; Inflammation; Literature review; Metabolism; Tumor necrosis factor

Indexed keywords

CYTOKINE;

ALCOHOL LIVER DISEASE; ANIMAL; DRUG ANTAGONISM; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CYTOKINES; HUMANS; LIVER DISEASES, ALCOHOLIC;

EID: 2342464756     PISSN: 0090838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. ADACHI, Y.; BRADFORD, B.; GAO, W.; BOJES, H.; AND THURMAN, R. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20:453-460, 1994.
2. ADACHI, Y.; MOORE, L.; BRADFORD, B.; GAO, W.; AND THURMAN, R. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218-224, 1995.
3. DULLEMEN, H.M.; VAN DEVENTER, S.J.H.; HOMMES, D.W.; BIJL, H.A.; JANSEN, J.; TYTGAT, G.N.J.; AND WOODY, J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129-135, 1995.
4. ELLIOTT, M.J.; MAINI, R.N.; FELDMANN, M.; KALDEN, J.R.; ANTONI, C.; SMOLEN, J.S.; LEEB, B.; BREEDVELD, F.; MACFARLANE, J.D.; BIJL, H.; AND WOODY, J.N. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994.
5. GAETKE, L.M.; MCCLAIN, C.J.; TALWALKAR, R.T.; AND SHEDLOFSKY, S.I. Effects of endotoxin on zinc metabolism in human volunteers. American Journal of Physiology 272:E952-E956, 1997.
6. HILL, D.B.; MARSANO, L.; COHEN, D.; ALLEN, J.; SHEDLOFSKY, S.; AND MCCLAlN, C.J. Increased plasma interleukin-6 activity in alcoholic hepatitis. Journal of Laboratory and Clinical Medicine 119:547-552, 1992.
7. HILL, D.; SHEDLOFSKY, S.; MCCLAIN, C.J.; DIEHL, A.M.; AND TSUKAMOTO, H. Cytokines and liver disease. In: Remick and Friedland, eds. Cytokines in Health and Disease. 2d ed. New York, NY: Marcel Dekker, Inc., 1996. pp. 401-425.
8. HONCHEL, R.; RAY, M.B.; MARSANO, L.; SHEDLOFSKY, S.; AND MCCLAIN, C. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcoholism: Clinical and Experimental Research 16:665-669, 1992.
9. IIMURO, Y.; GALLUCCI, R.M.; LUSTER, M.I.; KONO, H.; AND THURMAN, R.G. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530-1537, 1997.
10. KAMIMURA, S., AND TSUKAMOTO, H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22:1304-1309, 1995.
11. NANJI, A.A.; ZHAO, S.; SADRZADEH, S.M.; AND WAXMAN, D.J. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 19:1483-1487, 1994a.
12. NANJI, A.; KHETTRY, U.; AND SADRZADEH, S. LACTOBACILLUS feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proceedings of the Society for Experimental Biology and Medicine 295:243-247, 19946.
13. SHERON, N.; BIRD, G.; KOSKINAS, J.; PORTMANN, B.; CESKA, M.; LINDLEY, I; AND WILLIAMS, R. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 18:41-46, 1993.